(Q43737586)

26 November 2017

Coffee, caffeine, and the risk of liver cirrhosis (English)

1 reference

26 November 2017

0 references

0 references

2

1 reference

26 November 2017

G Corrao

1

1 reference

26 November 2017

V Bagnardi

3

1 reference

26 November 2017

A D'Amicis

4

1 reference

26 November 2017

A Klatsky

5

1 reference

26 November 2017

Collaborative SIDECIR Group

6

1 reference

26 November 2017

1 October 2001

1 reference

26 November 2017

Annals of Epidemiology

1 reference

26 November 2017

11

1 reference

26 November 2017

7

1 reference

26 November 2017

458-465

1 reference

Is serum gamma-glutamyltransferase a misleading test?

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

The Tromsø Heart Study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

The Tromsø Study. Distribution and population determinants of gamma-glutamyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Unexpected effects of coffee consumption on liver enzymes.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Coffee and serum gamma-glutamyltransferase: a study of self-defense officials in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Seven-year longitudinal population study of change in gamma-glutamyltransferase: the Tromsø Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Distribution and population determinants of gamma-glutamyltransferase in a random sample of Sardinian inhabitants. 'ATS-SARDEGNA' Research Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Determinants of gamma-glutamyltransferase: positive interaction with alcohol and body mass index, negative association with coffee.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Joint influence of alcohol, tobacco, and coffee on biological markers of heavy drinking in alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Coffee Drinking and Serum Gamma-Glutamyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Alcohol, smoking, coffee, and cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Exploring the role of diet in modifying the effect of known disease determinants: application to risk factors of liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Alcohol consumption and micronutrient intake as risk factors for liver cirrhosis: a case-control study. The Provincial Group for the study of Chronic Liver Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Infectivity of blood seropositive for hepatitis C virus antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Survival and prognostic indicators in compensated and decompensated cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Alcohol consumption and non-cirrhotic chronic hepatitis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Amount and duration of alcohol intake as risk factors of symptomatic liver cirrhosis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

A strong negative association between alcohol consumption and the risk of hepatocellular carcinoma in cirrhotic patients. A case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Differences in risk estimations from a hospital and a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

In vitro interaction between psychotropic drugs and alcohol dehydrogenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Attributable risk for symptomatic liver cirrhosis in Italy. Collaborative Groups for the Study of Liver Diseases in Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

Meta-analysis of alcohol intake in relation to risk of liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1047-2797%2801%2900223-X

7 January 2021

10.1016/S1047-2797(01)00223-X

Identifiers

DOI

1 reference

26 November 2017

1 reference